339 related articles for article (PubMed ID: 9568711)
1. Somatic inactivation of Pkd2 results in polycystic kidney disease.
Wu G; D'Agati V; Cai Y; Markowitz G; Park JH; Reynolds DM; Maeda Y; Le TC; Hou H; Kucherlapati R; Edelmann W; Somlo S
Cell; 1998 Apr; 93(2):177-88. PubMed ID: 9568711
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
Wu G; Somlo S
Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
[TBL] [Abstract][Full Text] [Related]
3. A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2.
Torra R; Badenas C; San Millán JL; Pérez-Oller L; Estivill X; Darnell A
Am J Hum Genet; 1999 Aug; 65(2):345-52. PubMed ID: 10417277
[TBL] [Abstract][Full Text] [Related]
4. Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.
Wu G; Tian X; Nishimura S; Markowitz GS; D'Agati V; Park JH; Yao L; Li L; Geng L; Zhao H; Edelmann W; Somlo S
Hum Mol Genet; 2002 Aug; 11(16):1845-54. PubMed ID: 12140187
[TBL] [Abstract][Full Text] [Related]
5. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations.
Watnick T; He N; Wang K; Liang Y; Parfrey P; Hefferton D; St George-Hyslop P; Germino G; Pei Y
Nat Genet; 2000 Jun; 25(2):143-4. PubMed ID: 10835625
[TBL] [Abstract][Full Text] [Related]
6. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
[TBL] [Abstract][Full Text] [Related]
7. Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease.
Pei Y; Watnick T; He N; Wang K; Liang Y; Parfrey P; Germino G; St George-Hyslop P
J Am Soc Nephrol; 1999 Jul; 10(7):1524-9. PubMed ID: 10405208
[TBL] [Abstract][Full Text] [Related]
8. Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease.
Koptides M; Hadjimichael C; Koupepidou P; Pierides A; Constantinou Deltas C
Hum Mol Genet; 1999 Mar; 8(3):509-13. PubMed ID: 9949210
[TBL] [Abstract][Full Text] [Related]
9. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
Wu G
Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
[TBL] [Abstract][Full Text] [Related]
10. Human polycystin-2 transgene dose-dependently rescues ADPKD phenotypes in Pkd2 mutant mice.
Li A; Tian X; Zhang X; Huang S; Ma Y; Wu D; Moeckel G; Somlo S; Wu G
Am J Pathol; 2015 Oct; 185(10):2843-60. PubMed ID: 26435415
[TBL] [Abstract][Full Text] [Related]
11. Mutations in autosomal dominant polycystic kidney disease 2 gene: Reduced expression of PKD2 protein in lymphoblastoid cells.
Aguiari G; Manzati E; Penolazzi L; Micheletti F; Augello G; Vitali ED; Cappelli G; Cai Y; Reynolds D; Somlo S; Piva R; del Senno L
Am J Kidney Dis; 1999 May; 33(5):880-5. PubMed ID: 10213643
[TBL] [Abstract][Full Text] [Related]
12. Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease.
Koptides M; Mean R; Demetriou K; Pierides A; Deltas CC
Hum Mol Genet; 2000 Feb; 9(3):447-52. PubMed ID: 10655555
[TBL] [Abstract][Full Text] [Related]
13. Cardiac defects and renal failure in mice with targeted mutations in Pkd2.
Wu G; Markowitz GS; Li L; D'Agati VD; Factor SM; Geng L; Tibara S; Tuchman J; Cai Y; Park JH; van Adelsberg J; Hou H; Kucherlapati R; Edelmann W; Somlo S
Nat Genet; 2000 Jan; 24(1):75-8. PubMed ID: 10615132
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.
Badenas C; Torra R; Pérez-Oller L; Mallolas J; Talbot-Wright R; Torregrosa V; Darnell A
Eur J Hum Genet; 2000 Jul; 8(7):487-92. PubMed ID: 10909847
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of autosomal dominant polycystic kidney disease.
Al-Bhalal L; Akhtar M
Adv Anat Pathol; 2005 May; 12(3):126-33. PubMed ID: 15900113
[TBL] [Abstract][Full Text] [Related]
16. Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.
Park EY; Sung YH; Yang MH; Noh JY; Park SY; Lee TY; Yook YJ; Yoo KH; Roh KJ; Kim I; Hwang YH; Oh GT; Seong JK; Ahn C; Lee HW; Park JH
J Biol Chem; 2009 Mar; 284(11):7214-22. PubMed ID: 19098310
[TBL] [Abstract][Full Text] [Related]
17. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2).
Hayashi T; Mochizuki T; Reynolds DM; Wu G; Cai Y; Somlo S
Genomics; 1997 Aug; 44(1):131-6. PubMed ID: 9286709
[TBL] [Abstract][Full Text] [Related]
19. [Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].
Pérez-Oller L; Torra R; Badenas C; San Millán JL; Darnell A
Nefrologia; 2000; 20(2):130-8. PubMed ID: 10853193
[TBL] [Abstract][Full Text] [Related]
20. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
